Apogee Therapeutics Secures Up To $1.3 Bln Financing From Blackstone For Zumilokibart
27/5 13:22
(RTTNews) - Apogee Therapeutics, Inc. (APGE) on Wednesday announced a financing partnership with Blackstone Life Sciences that could provide up to $1.3 billion in non-dilutive capital to help advance and potentially commercialize its lead drug candidate, zumilokibart....